Safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database

Background: Tirzepatide has demonstrated superior efficacy in glycemic control and weight reduction compared to existing GLP-1 receptor agonists. However, its safety profile remains to be fully elucidated in real-world settings. This study examines its safety profile using the EudraVigilance databas...

Full description

Saved in:

Bibliographic Details
Main Authors:	Atul Khurana (Author), Syed Arman Rabbani (Author), Mohamed El-Tanani (Author), Mandeep Kumar Arora (Author), Shrestha Sharma (Author), Harikesh Dubey (Author), Alaa A. Aljabali (Author), Murtaza M. Tambuwala (Author)
Format:	Book
Published:	Elsevier, 2024-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database
by: Fabrizio Calapai, et al.
Published: (2023)

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database
by: Giuseppe Cicala, et al.
Published: (2024)

Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database
by: Michael Magdy Fahmy Girgis, et al.
Published: (2024)

Drug-Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database
by: Carmen Maximiliana Dobrea, et al.
Published: (2024)

Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007-2018
by: Iwona Popiołek, et al.
Published: (2019)

Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance
by: Fabrizio Calapai, et al.
Published: (2024)

Evaluation of quantitative signal detection in EudraVigilance for orphan drugs: possible risk of false negatives
by: Marco Sardella, et al.
Published: (2019)

Post-Marketing Surveillance of Statins-A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance
by: Gabriela Pop, et al.
Published: (2022)

A Descriptive Analysis of Direct Oral Anticoagulant Drugs Dosing Errors Based on Spontaneous Reports from the EudraVigilance Database
by: Claudiu Morgovan, et al.
Published: (2023)

Suspected oncologic adverse reactions associated with interleukin‐23 inhibitors in EudraVigilance: Comparative study and gender distribution
by: Fabrizio Calapai, et al.
Published: (2023)

Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database
by: Cristina Scavone, et al.
Published: (2022)

Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database
by: Liberata Sportiello, et al.
Published: (2023)

Characteristics and completeness of spontaneous reports by reporter's role in Germany: An analysis of the EudraVigilance database using the example of opioid‐associated abuse, dependence, or withdrawal
by: Kathrin Jobski, et al.
Published: (2023)

A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated <i>Clostridioides difficile</i> Infection Based on Reports from the EudraVigilance Database: Analysis of Some of the Most Used Antibiotics in Intensive Care Units
by: Bogdan Ioan Vintila, et al.
Published: (2023)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)
by: Stefania Chiappini, et al.
Published: (2022)

Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility
by: Michele Gringeri, et al.
Published: (2021)

Tirzepatide for type 2 diabetes
by: Sarah L Anderson, et al.
Published: (2023)

The Tirzepatide Drop: Beware of Slimmer's Paralysis
by: John M. Tucker MD, et al.
Published: (2024)

Tirzepatide - A Revolution in Obesity Treatment?
by: Aleksandra Jaroń, et al.
Published: (2024)

Tirzepatide - a new analogue of incretin hormones
by: Gabriela Anglart, et al.
Published: (2023)

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
by: Wang L
Published: (2022)

Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide
by: Karen Schneck, et al.
Published: (2024)

A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database
by: Liyuan Liu
Published: (2024)

Treatment of insulin resistance with tirzepatide leading to improvement of hair loss
by: Emily R. Gordon, BA, et al.
Published: (2024)

The Vigil of Medicine
by: Kiersten Kelly
Published: (2021)

Biomedical applications of three‐dimensional bioprinted craniofacial tissue engineering
by: Nitin Bharat Charbe, et al.
Published: (2023)

Will Tirzepatide become a game-changer in the pharmacological treatment of obesity? - literature review
by: Aleksandra Doryń, et al.
Published: (2024)

The Vigilance Committee of 1856
by: O'Meara, James, 1825-1903

Introducing Vigilant Audiences
Published: (2020)

Introducing Vigilant Audiences
Published: (2020)

Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue
by: Ricardo J. Samms, et al.
Published: (2022)

Revolutionizing Diabetes and Obesity Management: A Comprehensive Review of Tirzepatide's Dual Agonist Approach
by: Sonam Samal, et al.
Published: (2024)

Efficacy and safety of tirzepatide in patients with type 2 diabetes: A systematic review and meta-analysis
by: Yan Tang, et al.
Published: (2022)

Tirzepatide: Does the Evidence to Date Show Potential for the Treatment of Early Stage Type 2 Diabetes?
by: Razzaki TS, et al.
Published: (2022)

Tirzepatide's innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health
by: Jingqi Yang, et al.
Published: (2024)

Semaglutide versus Tirzepatide - comparison of both drugs in treatment of diabetes type 2 and weight reduction
by: Arkadiusz Staroń, et al.
Published: (2024)

Vigilance et transports Aspects fondamentaux, dégradation et prévention
Published: (1995)

Tirzepatide - a new hope for type 2 diabetes mellitus and obesity management. A literature review.
by: Izabela Stawicka, et al.
Published: (2024)

Prediction of pediatric dose of tirzepatide from the reference adult dose using physiologically based pharmacokinetic modelling
by: Ruifang Guan, et al.
Published: (2023)

Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis
by: Emiko Otsuka, et al.
Published: (2024)